As part of the programme, BEVA is giving the coaches workshops, discussion forums and online toolkits to develop their mentoring skills. Having been trained by a specialist mentoring professional, the coaches are then paired with recent graduates to give them guidance and support during the foundation years of their careers.
The project, called 'Leg Up', has been driven by BEVA President Renate Weller, and is being trialled over the next 12 months before being rolled out more widely.
Renate said: "All professionals, but especially new graduates need support in navigating their journey through their chosen career.
"With the veterinary industry’s rapidly changing landscape and rising concern around wellbeing, consistent support and guidance have never been more relevant."
Coaching is open to BEVA concessionary members who have graduated within the past three years. They will be able to self-select a preferred coach on a first come, first served basis from the Leg Up section of the BEVA website.
Renated added: "To date access to targeted careers support has most often depended on where you work and who you know. We hope the scheme will encourage and support those entering the profession, giving them the opportunity to discuss their training, development, career progression and self-care with trained professionals who were once in their shoes."
To find out more and to sign up for the Leg Up programme visit https://www.beva.org.uk/Careers/Leg-Up
Katie, who works at Milbourn Equine, is now preparing with her horse Templar Justice, or TJ for short, to take part in what is widely acknowledged to be one of the world's most difficult equestrian events.
Last year, she competed at the Burghley Horse Trials and was voted "Amateur Rider of the Year" by Horse and Hound magazine.
Katie says she is determined to build on that success with a strong showing at Badminton: "The Burghley Horse Trials were amazing last year. I was so excited to be there and it went so well. To now be competing at Badminton will be an awesome experience.
"It’s one of only six 'five-star' equestrian events in the world and to compete there really is my dream come true."
Virbac has launched Neoprinil, an eprinomectin pour-on solution indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles.
Neoprinil has a zero-day withdrawal period in milk and can be administered using the company's Farmpack and Flexibag.
The Farmpack is a backpack which holds a Flexibag of Neoprinil solution. The Flexibag is a bag designed to protect medication and preserve it once it has been opened. The two together were awarded the 2014 PharmaPack Award for Innovative Packaging.
Neoprinil offers a one year stability period once it has first been opened and requires no special conditions for storage. It is presented in 2.5L, 4.5l and 8l pack sizes.
Product Manager for Large Animals Brigitte Goasduf MRCVS said: "A high worm burden can have adverse effects on the herd's productivity and performance and so it is advisable to ensure infected animals are treated as part of a Herd Health Plan. Eprinomectin is a tried and trusted parasiticide and studies confirm that it can have a positive impact on both milk production and on weight gain. Its zero day withdrawal period is a major benefit for dairy farmers.
"With the launch first of Deltanil and, now, Neoprinil, we are reinforcing our commitment to work with veterinary surgeons and farmers to understand the everyday challenges they face and to provide practical, effective solutions. We offer a comprehensive parasiticide range with a dispensing system that sets a new standard for convenience and ease of use."
The Small Animal Medicine Society has become the very first veterinary society to use online social networking to bring its members closer together, with its own dedicated section within this site.
The new SAMSoc section of VetSurgeon contains a host of features to facilitate the sharing of ideas, experiences and knowledge amongst the society's members. There's a photo and video sharing gallery in which to share and discuss interesting cases. There's a dedicated forum to debate current issues and ask SAMSoc advice about difficult cases. Members can also catch up on association news and hold private 'conversations' between each other using VetSurgeon's sophisticated peer-to-peer communication system.
All veterinary surgeons can visit the SAMSoc section on VetSurgeon.
However, only SAMSoc members can use the various features and participate. A downloadable application form for SAMSoc membership is available from the 'About us' section.
Ian Battersby MRCVS, SAMSoc committee member said: "We're very excited about the potential that VetSurgeon offers us to share knowledge about small animal medicine more effectively amongst our members."
Arlo Guthrie, editor and publisher of VetSurgeon said: "I'm delighted about SAMSoc joining VetSurgeon; bringing vets together and sharing knowledge is what the site is all about."
He added: "We are able to offer dedicated sections of VetSurgeon to other veterinary societies and associations, free of charge. So, if you represent one, do take a look at the SAMSoc section on VetSurgeon. If you like what you see, get in touch with me."
The NOAH Code of Practice Committee, chaired by Mr Guy Tritton, has found Dechra Veterinary Products in breach of three items of the NOAH Code, following a complaint.
The complaint related to an advertisement and detailer promoting Felimazole with the wording "Are you taking a heavy-handed approach to hyperthyroidism?" and "with Felimazole, you don't have to!"
The Committee took the view that by implication this referred to Vidalta because Vidalta is the only other licensed oral treatment on the market for hyperthyroidism.
As a result, the Committee found both promotions in breach of Clause 4.3 because of the implication that Vidalta is less safe than Felimazole.
The Committee did not consider the promotions disparaged the manufacturer as there is no evidence to show it is unsafe.
The Committee also found that the table in the detailer (page 4) suggesting that one dosage of 5 mg per day of Felimazole has the same efficacy as two doses of 2.5 mg, (which is contrary to the dosing statement within the SPC: "If, for reasons of compliance, once daily dosing with a 5 mg tablet is preferable, then this is acceptable although reduced efficacy can be expected compared to a twice daily regime.") was misleading, contrary to Clause 4.3 of the Code.
Full details of the Committee's rulings are on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The study, which was carried out by the VetCompass programme at the RVC, in partnership with Vets Now, also found that cats are most likely to be involved in a traffic accident in the autumn.
1,407 cat road traffic accident cases that attended Vets Now clinics across the UK between December 2011 and February 2014 were analysed, with researchers finding:
Younger cats, aged six months to six years, are at the greatest risk of road traffic accidents.
Male cats are 1.3 times more at risk of road traffic accidents than female cats.
Crossbred cats are 1.9 times more at risk of road traffic accidents compared to purebred cats.
Cats are more likely to be involved in a road traffic accident in the autumn. However, they are less at risk in winter as compared to spring.
Those cats that present with abdominal or spinal injuries are more likely to die, as are those that present with an increasing count of injuries.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "One of the scariest times for any cat-owner is when they first start to let their cat go outside unattended. Owners of younger, and especially male, cats need to be especially vigilant. These results help owners to understand the true risks and therefore assist these owners to make the best decisions about if and how they let their cats go outside."
Dr Amanda Boag, Clinical Director of Vets Now, said: "We are very proud to have worked with VetCompass to ensure this important information about risks to our pet cats is made available to vets and the public. Working with our partners such as the RVC, we are committed to ensuring our large clinical database is used to help advance veterinary knowledge and understanding of emergency and critical care practice."
The full paper entitled 'Epidemiology of Road Traffic Accidents in Cats attending emergency-care practices in the UK' is published in the Journal of Small Animal Practice.
Mandisa (pictured right) was first elected to Council in 2014 and then re-elected last year. She is currently Chair of the Practice Standards Group, which coordinates the RCVS Practice Standards Scheme, and a member of the Primary Qualifications Subcommittee and the Legislation Working Party. She has also served on Standards Committee and as well as chairing the Extra-Mural Studies (EMS) Coordinators Liaison Group.
Born in the UK, and raised in Trinidad & Tobago in the West Indies from the age of two, Mandisa moved back to the UK aged 18 to study for a BSc in Biological and Medicinal Chemistry at the University of Exeter. She then gained her veterinary degree from the Royal (Dick) School of Veterinary Studies at the University of Edinburgh in 2008.
Since graduating, her interests have lain in small animal practice and emergency and critical care, and she has worked as a veterinary surgeon in a number of practices in the West Midlands. She currently works for Medivet in the Staffordshire town of Newcastle-under-Lyme and lives in Stoke-on-Trent. She is a published author, having been the researcher on a paper about genomic variations in Mycobacterium published in BMC Microbiology.
More information about RCVS Council and its members can be found at: www.rcvs.org.uk/who-we-are/rcvs-council/
Photo: Copyright RCVS
CEVA Animal Health's live enzootic abortion vaccine, CEVAC® Chlamydophila, has been renamed CEVAC® Chlamydia and repackaged in a larger bottle size.
According to the company, infectious abortion, particularly enzootic abortion (Chlamydiosis) can wipe out up to 50% of lambs but strategic use of CEVAC Chlamydia, a live enzootic abortion vaccine, can help keep the flock safe. It can prevent abortion and also control excretion and the threat of infection. For added convenience CEVAC Chlamydia can be used on the same day as the toxoplasmosis vaccine. This can save administration time and money.
For extra efficiency with big flocks CEVAC Chlamydia is now available in a larger, 50 dose bottle in addition to the original 20 dose bottle. It is administered using a special multi-dose injector gun.
CEVA says that a strategic vaccination every four years will help flocks remain chlamydiosis-free. Routine preventative measures are also advised prior to mating and when new sheep are introduced to the flock, to ensure abortion and infection rates always remain as low as possible. All animals should be vaccinated in the first year, with replacements being vaccinated from six months of age, at least four weeks prior to tupping.
For further product information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG or visit the website at www.ceva.uk.com
The British Veterinary Association has welcomed the tightening up of sales of veterinary medicines on the internet but has expressed disappointment that the advertising of antimicrobials to farmers will continue.
The Veterinary Medicines Directorate has today published its response to the public consultation on the Veterinary Medicines Regulations, which are updated every year.
The new Regulations, which come into force in April 2011, introduce new controls on internet pharmacies meaning that only approved websites will be legally allowed to dispense and supply veterinary medicines. The controls will come into force in April 2012 and the BVA supports the use of a logo on approved websites to help consumers buy medicines from reputable sources.
The BVA has previously expressed concern that pet owners could inadvertently buy counterfeit veterinary medicines online and urges veterinary clients to seek advice from their vet and only buy from UK-based companies.
Harvey Locke, President of the BVA, said: "Without proper regulation online pharmacies could be sourcing drugs from overseas and selling counterfeit medicines that look genuine to unsuspecting pet owners. These medicines are placebos at best and dangerous at worst.
"We therefore welcome the VMD's decision to clampdown on irresponsible online retailers and provide a clear logo for approved websites that will give pet owners confidence.
"We have also asked the VMD to put a stop to the increasing problem of prescription fraud and we hope the tighter regulation announced today will be a step towards achieving that aim.
"However, we would urge all pet owners to continue talking to their vet about sourcing medicines from the internet to make sure the right drugs are bought and administered correctly."
In light of increasing concerns about the growth of antimicrobial resistance the VMD's consultation canvassed views on restricting the advertising of antimicrobials to farmers. The BVA says it supported a ban on advertising as a sensible approach to the responsible use of antimicrobials, and is disappointed that the VMD has decided not to go ahead with it. Mr Locke said: "New antimicrobials are heavily advertised by pharmaceutical companies to vets and farmers so it is vital that the message of responsible use is not lost.
"Antimicrobial resistance is a serious issue for both animal and human health and we are disappointed that the VMD is not restricting the advertising of these products to farmers. The pharmaceutical companies must now undertake to advertise responsibly.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets and farmers should work together to ensure antimicrobials are used prudently and responsibly."
Chris, who is moving from Willows, will develop both the medical cardiology service and deliver a new interventional cardiology service to complement the existing surgical offering at Paragon, which is investing around £145,000 in ultrasound equipment and operating facilities to support the service.
Chris said: “I’ve had a great time at Willows and couldn’t think of a better place than Paragon to continue my passion for all things cardiology.
“It’s an exciting time to be joining Paragon, which is growing phenomenally to service the region whilst it cements itself as one of the leading referral centres in the north of England.
“The investment and expansion which is taking place at Paragon will allow us to develop another globally-recognised cardiology centre within Linnaeus.”
For more information, visit: www.paragonreferrals.co.uk
The responsible use of antibiotics termed critically important is an important strand in the UK policy to fight antibiotic resistance development.
However, NOAH says there is much confusion about which antibiotics should be considered within this group, with different organisations referring to different classes.
Donal Murphy, Head of Technical and Regulatory Affairs at NOAH said: "NOAH believes the classification and use of antibiotics in veterinary medicine should be driven and guided by the regulators, who are independent and make science based decisions and recommendations.
"Of course, all classes of antibiotics, whether critically important or not, should be used responsibly and guided by the principle outlined by the Responsible Use of Medicines in Agriculture Alliance (RUMA) who state they should be used 'as little as possible but as much as necessary'. The use of these important products in this manner can ensure that the availability and efficacy of antibiotics can be maintained to ensure animal health and welfare in the future."
You can download the briefing document here.
Matt Yarnall from Boehringer Ingelheim said: "This is fantastic news for Bovela which offers a truly unique and innovative way of controlling BVD in a herd, something that is now clearly being appreciated by farmers and vets alike."
The company says over 5 million doses of Bovela have now been sold across Europe2 showing how quickly farmers have understood the benefits of a single dose vaccine that provides a full 12 months of live vaccine protection.
Matt added: "Feedback we have from vets and farmers throughout Europe shows two main things. Firstly, for those who haven’t controlled BVD before, there is the realisation of how much better herd health can be and secondly, for those who have previously struggled with multiple primary course vaccines or those that should be boosted every six months, there is relief at Bovela’s easy-to-follow regime."
References
The epidemic of respiratory disease in early 2010 was characterised by coughing and nasal discharge.
The disease spread through the population of 77,000 Icelandic horses within weeks, leading to a self-imposed ban on their export and significant economic cost to the country.
Initially, due to the speed at which the disease had spread, a viral cause was suspected. However, investigations by researchers at the University of Iceland showed that only Streptococcus zooepidemicus was consistently recovered from coughing horses and rare fatal cases of infection. However, this bacterium is also often found in healthy horses.
The AHT and the Wellcome Trust Sanger Institute were brought in to investigate. Dr Simon Harris from the Wellcome Trust Sanger Institute said: "To identify the culprit, we sequenced the DNA from 257 samples of bacteria from diseased animals and people. This showed that one specific strain of S. zooepidemicus, called ST209, was the likely culprit, and we also found this strain in a human case of blood poisoning. This study highlights, for the first time, how DNA sequencing can be used to identify endemic strains of bacteria and distinguish them from the cause of an epidemic infection."
Iceland is free of all major equine infectious diseases thanks to the ban on the importation of horses into the country in 1882. Consequently, Icelandic horses are particularly susceptible to any new bacteria or virus that crosses the border, and so strict biosecurity regulations are in place to help protect them.
Dr. Sigríður Björnsdóttir of the MAST Icelandic Food and Veterinary Authority, used information from owners and veterinary surgeons to build an epidemiological network. This enabled her to identify an equine rehabilitation centre where horses exercised in a water treadmill. The water treadmill is thought to have provided the perfect conditions for transmitting the disease as water was splashed up and ingested. Horses would complete their rehabilitation and return home, whilst incubating the disease, taking the infection with them.
The ST209 strain of S. zooepidemicus found in Iceland has also been recovered from a coughing horse in Sweden and an abdominal abscess in a Finnish horse trainer.
Dr Andrew Waller, Head of Bacteriology at the AHT, said: "There are a couple of theories as to how the strain entered Iceland. These bacteria are able to survive outside a horse for a week or so, which means the import of contaminated equipment or clothing is the most likely route by which ST209 entered Iceland. However, this particular strain could have even infected a human who travelled to Iceland, before spreading the strain back to a horse and triggering the epidemic.
"We are delighted to have helped uncover the likely identity of the cause of this epidemic. Our investigation highlights the ability of S. zooepidemicus strains to cause disease in animals and people. We found evidence that even endemic strains of S. zooepidemicus were likely causing cases of respiratory disease in Icelandic horses, illustrating that this group of bacteria causes more clinical problems in horses than was previously thought. We hope that raising awareness of the cause of this epidemic, and the likely involvement of a water treadmill as a key factor in disease transmission, will encourage veterinarians around the world to improve disease control precautions preventing future epidemics."
The first, which covers three topics: canine uveitis, canine glaucoma and non-healing corneal ulcer, is for the entire practice. It normally costs £95 per practice, but for VetSurgeon.org members, it's £70.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLScSSbUDCcC53cvPJtj1oPkJFEoDjJ3Tdij_y9iFtr7emBvkoQ/viewform?usp=pp_url
The second course is 'Ophthalmic Examination in the Dogs and Cats', which costs £25 for VetSurgeon.org members, that is reduced to £15 per person.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLSfnBizM5NmFGwWeDqtdXy9zCq8KdFgGI2e5D8pjuWOTuPln0Q/viewform?usp=pp_url
Originally from Belgium, Tamir, who qualified at Glasgow in 2001, started Vision Vet in 2009 and gained his National French Certificate in Ophthalmology (broadly equivalent to the UK Cert) in 2011.
https://www.vision-vet.co.uk
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
CVS says that in the USA, the veterinary profession is the fifth highest profession for non-fatal injuries, with equine veterinarians sustaining an average of eight serious injuries during their career.
‘The context, consequence and prevention of veterinary workplace injuries: a qualitative and quantitative study in the UK’ will be undertaken at the University of Liverpool in collaboration with CVS colleagues as part of its Clinical Research Awards.
The study will run for three years, supported by £74,400 of CVS funding.
The research will investigate what veterinary injuries are, what context they occur in and what their consequences are.
It will look to highlight areas of the profession where injury prevention training and strategies can be developed and adopted to improve the safety of working in veterinary practice.
For the first phase, University of Liverpool researchers have rolled out the largest ever survey to explore veterinary workplace injuries with over 5,000 CVS staff UK-wide.
The survey investigates how veterinary professionals define injuries, their specific causal mechanisms, and why individuals do or do not report injuries or seek medical treatment.
The survey will be followed by an independent audit of CVS’ accident reporting system.
The results of these two activities will lead to the development of a suite of industry leading ‘open access’ educational tools aimed at promoting injury awareness and prevention to help drive behaviour change and support injury avoidance.\
The research project is being led by Dr. John Tulloch, a Research Fellow and European Specialist in Veterinary Public Health, at the University of Liverpool.
Collaborators include CVS Head of Health and Safety Rebecca Jackson and Director of Learning, Education and Development Dr Martin Whiting.
John said: “Injuries that occur within veterinary practice can tragically at times be life-changing and are often avoidable.
"Currently we do not know some critical details that would help to improve safety within the veterinary workplace.
"If we can better understand these details, we will be able to develop and strengthen prevention measures through policy, education, and training.
"We anticipate that this project will result in safer workplaces within the wider veterinary community and, indirectly, in improved animal treatment through a fitter, healthier and safer profession.”
Mr Ng faced seven charges:
Mr Ng admitted some aspects of the charges against him, including that he had deleted two patient records and that this was dishonest and misleading.
The Committee then determined the facts of the rest of the charges after hearing evidence from witnesses and Mr Ng himself, as well as expert witnesses.
Having considered all the evidence, it determined which elements of the charges were proved, and which were not.
The Committee then considered whether the admitted and charges found proved amounted to serious professional misconduct.
In doing so it considered that the charges against Mr Ng fell into three broad categories – deficiencies in clinical care, deficiencies in record keeping, and dishonesty.
In respect of all three, it found the admitted and charges found proved amounted to serious professional misconduct.
In terms of aggravating factors, the Committee found that Mr Ng’s conduct had directly caused harm to animals and also created risk of further harm, and noted that there were three instances of dishonesty.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee noted that there were three instances of dishonest behaviour in relation to clinical records.
"The amendment of the clinical record in the labradoodle’s case was particularly serious.
"This alteration was made at a time when the respondent knew that the owner was dissatisfied with the treatment the dog had received and was complaining about the lack of therapeutic intervention.
"The alteration presented a false account of the owner’s attitude towards immediate therapeutic intervention.
"Conduct of this kind was liable to damage trust in the profession.”
In mitigation, the Committee took into account the sense of pressure Mr Ng felt following a financial dispute with his relative in respect of the veterinary practice, his long career as a veterinary surgeon and the high regard with which he was held by those who provided testimonials on his behalf.
The Committee acknowledged Mr Ng’s assertions that he now understood his failings and his expressions of remorse for the harm he had caused and that these indicated the beginnings of insight.
However, in respect of the clinical deficiencies, the Committee found that various aspects of Mr Ng’s approach to treating conditions such as diabetes and cherry eye were inadequate and out-of-date, and that there was little in his continuing professional development (CPD) record or his statements to suggest he had attempted to improve these deficiencies.
Ultimately, the Committee found that Mr Ng’s conduct was so serious that removal from the Register was the most appropriate sanction.
Paul Morris added: “The Committee has concluded that the respondent’s behaviour was fundamentally incompatible with being a veterinary surgeon.
"In view of the nature and gravity of the Committee’s findings in this case, removal from the Register is necessary to ensure the protection of animals and the maintenance of public confidence in the profession and the regulatory process.”
www.rcvs.org.uk/disciplinary
The RCVS Disciplinary Committee has directed that the name of a veterinary surgeon who formerly practised in Norwich should be removed from the Register, having found him unfit to practise veterinary surgery following his Crown Court conviction for fraud.
During the one-day hearing, the Disciplinary Committee heard how Francisco da Cruz had abused his position whilst practising as a veterinary surgeon at Hellesdon Vets, his then workplace in Norwich, by defrauding a insurance companies of around £10,000 with fictitious claims for veterinary treatment on non-existent pets.
Following an investigation by the City of London Police's Insurance Fraud Enforcement Department (IFED), Mr da Cruz was convicted on five counts of fraud by false representation on 21 February 2013 at the Old Bailey in London, and later sentenced to eight months' imprisonment (suspended for two years) and 200 hours of unpaid community work; he was also ordered to pay just over £10,000 in compensation and costs.
Although Mr da Cruz had left the UK for Brazil shortly after his sentencing and was therefore not present at the hearing, the Committee was satisfied that he was deliberately evading the disciplinary proceedings, rather than being genuinely unable to participate in them, and so the hearing proceeded in his absence.
First accepting the copy certificate of conviction against Mr da Cruz as true, the Committee then had no hesitation in concluding that these convictions rendered him unfit to practise as a member of the veterinary profession. It found that the five counts of fraud were deliberate crimes of dishonesty, committed over a significant period of time and for significant financial gain. He had abused his position as a veterinary surgeon and abused the trust which the insurers placed in him as a professional.
Chairing and speaking on behalf of the Committee, Professor Peter Lees, said: "The Committee has no real confidence that there is no significant risk of repeat behaviour from the Respondent. His conduct subsequent to the criminal proceedings gives it no confidence that he has reformed himself to the extent that he will in the foreseeable future be fit to return to practice. So far from satisfactorily completing his criminal sentence, it appears that the Respondent has deliberately gone abroad to avoid doing so."
Bearing in mind that the purpose of any sanction it imposed was not to punish Mr da Cruz, but to maintain public confidence in the profession and uphold proper standards of conduct within it, the Committee concluded that the convictions were too serious to allow any sanction other than removal from the Register.
The full details of the Committee's decisions are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Ceva Animal Health has launched Cardio Academy. The company says it's the first international cardiology e-learning programme offering CPD from leading international specialists.
The programme can be accessed at www.cardioacademy.cevalearn.com. It consists of a series of impressively well-produced interactive multimedia presentations lasting around 30 minutes, at the end of which you can download a CPD certificate.
The first two sessions, which are now available online, cover the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, and Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec.
Product manager, Fraser Broadfoot MRCVS, said: "There have been many advances in the diagnosis and treatment of heart failure in recent years. The aim of this website is to become a practical and up-to-date resource on the management of heart failure in practice."
Merial Animal Health has launched Locatim, an oral antibody supplement to aid calf scour management.
Manufactured from the colostrum of high health status cows that are hyper-immunised against E.coli, rotavirus and coronavirus, Locatim contains a guaranteed concentration of specific antibodies to enterotoxic E.coli F5 (K99).
Merial says that when given alongside the dam’s colostrum, Locatim provides enhanced protection against infection, reducing calf mortality due to neonatal diarrhoea caused by E.coli F5 (K99), and helping to protect calf health during the critical rearing period.
According to the company, a single 60ml oral dose provides direct transfer of these specific antibodies, giving local protection within the digestive tract and systemic protection following absorption through the intestinal mucosa.
For optimal absorption Locatim should be administered during the first four hours of life, but it can be given up to 12 hours after birth.
Locatim can be administered to every calf born during an outbreak of scour; at times of peak calving, when environmental challenge is high; or it can be used to enhance protection in individual calves identified as being at high risk of disease due to factors such as dystocia, weakness or the poor quality of the dam’s colostrum.
For information on purchasing stock contact your local Merial Animal Health territory manager.
This was the sixth time that Mr Warwick Seymour-Hamilton had applied for restoration after being removed from the Register in June 1994, the reasons for which related to the condition of his practice premises and his record-keeping following an inspection by the RCVS. His most recent restoration hearing took place in May 2017.
In his application Mr Seymour-Hamilton said that he wanted to be restored to the Register to aid his research into herbal medicines and, during the course of the hearing, he also challenged some of the evidence given to the Committee in the June 1994 hearing. In particular he challenged the assertion that his practice was open when it was inspected by the RCVS as, he submitted that, he had retired three weeks’ prior to the inspection due to ill-health.
Mr Seymour-Hamilton told the Committee that he did not wish to return to clinical practice but wished to restore his membership of the RCVS in order to prescribe his own herbal treatments and to obtain peer review that would allow his treatments to be licensed. Furthermore, he produced, during the hearing, a continuing professional development (CPD) record card in which he had logged 1,438 hours of CPD in 2017.
In considering his application for restoration the Committee dismissed his challenge to the details of his original hearing in June 1994.
Ms Judith Way, Chairing the Committee and speaking on its behalf, said: "The Committee has noted that this issue is ancient. It is not for this Committee to consider it. Moreover the finding of the Committee represents a determination which was not challenged by the applicant until one of the more recent restoration applications. He never appealed it. Nor did he attend at the original hearing. It acknowledges that the premises could well have been closed given their condition, but whether they were or not is not for it [the Committee] to decide. It is quite possible the applicant has persuaded himself of the position. This is not an issue which is a persuasive factor in this application."
Regarding Mr Seymour-Hamilton’s contention that he would use his RCVS registered status to further his research into herbal treatments Ms Way said: "The Committee accepted there were no direct public protection issues which caused it concern, although it did retain some anxiety that the applicant’s commitment to herbal medicine could govern the way in which he would wish to care for an animal. A more rounded veterinary approach, which involved a full evaluation of an animal’s condition, a coherent diagnosis and a subsequent discussion about treatment with the client is called for."
Turning to his CPD she added: "His CPD now has a bias for herbal medicine as does his extensive reading. The Committee was not satisfied that his skills are up-to-date and that he could practise veterinary medicine safely. The Committee was not satisfied that he would approach a sick animal with the full and rounded approach required of a veterinary surgeon. Nor did his confidence in this regard allay the concerns of the Committee. He expressed belief in himself on the basis of his practice which came to an end some 24 years ago."
The Committee did acknowledge that Mr Seymour-Hamilton’s removal from the Register had a considerable impact on him and that, not only is he ashamed of it, but he believes it is frustrating his ability to advance the cause of herbal medicine.
In conclusion, Ms Way said: "Taking all these matters into account, the Committee has concluded that the applicant has not satisfied it on all of the evidence that he is fit to be restored to the Register and so this application is refused."
New research led by academics at the University of Bristol's School of Veterinary Sciences has shown that 85% of pet cats are not neutered by the recommended age of four months, possibly due to cat owners needing better information about when to neuter their cat.
In 2006, the recommended neutering age of pet cats reduced from six to four months of age. The study assessed the proportion of cats neutered at these ages. Data was obtained from owner-completed questionnaires at recruitment, when kittens were aged eight to 16-weeks, and six and a half to seven months of age. Demographic and lifestyle factors were also assessed for potential association with neuter status.
The researchers found that of the 751 cats in the study, 14.1% and 73.5% had been neutered at or before four and six months of age, respectively. Cats were significantly more likely to be neutered at four months if their owners had always intended to have their cat neutered by this age. They were also significantly more likely to be neutered at four months if they were microchipped or from households in deprived regions.
The likelihood of being neutered, compared with unneutered, at six months of age was significantly increased for cats that were insured, obtained from an animal welfare organisation, given their second vaccination, from a household with an annual income of over £10,000 and owned by people intending to have their cat neutered by this age.
Dr Jane Murray, Cats Protection Research Fellow in Feline Epidemiology, said: "Neutering is recommended as an effective way of reducing the number of unwanted cats in the UK. Our study found that age of neutering was associated with the age of intended neutering. Cats can reach puberty at four to five months of age therefore, it is important that owners are aware of the recommended age of neutering at four months, to reduce the number of unplanned pregnancies that occur."
The study suggests that while neutering rates were high at six months of age, they were low at four months of age, and that further work is required to publicise the recommended neutering age of four months to cat owners.
Paper: The neuter status of cats at four and six months of age is strongly associated with the owners' intended age of neutering, C. P. Welsh, T. J. Gruffydd-Jones and J. K. Murray, Veterinary Record published online April 19, 2013.
Bayer Animal Health has announced the launch of Ceffect (cefquinome), for the treatment of bacterial infections in cattle and pigs caused by Gram-positive and Gram-negative micro-organisms sensitive to cefquinome.
Ceffect is available as a 25mg/ml suspension for injection of cattle and pigs, and as Ceffect LC, a 75mg intramammary ointment for lactating cows.
In cattle, Ceffect 25mg/ml suspension for injection is licensed for the treatment of respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica, and also for the treatment of digital dermatitis, infectious bulbar necrosis, acute interdigital necrobacillosis, and acute E.coli mastitis with signs of systemic involvement.
In calves, Ceffect 25mg/ml suspension for injection is licensed for the treatment of E.coli septicaemia
In pigs, Ceffect 25mg/ml suspension for injection targets cefquinome-sensitive organisms including Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae and Streptococcus suis which can cause bacterial infections of the lungs and respiratory tract. It is also licensed for the treatment of Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of E.coli, Staphylococcus spp., Streptococcus spp. and other cefquinome-sensitive organisms.
In piglets, Ceffect 25mg/ml suspension is licensed for the reduction of mortality in cases of meningitis caused by Streptococcus suis. For the treatment of arthritis caused by Streptococcus spp., E. coli and other cefquinome-sensitive organisms, and epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.
Ceffect LC, 75mg intramammary ointment for lactating cows also contains cefquinome and comes in individual 8g prefilled syringes for treatment of clinical mastitis caused by Streptococcus uberis, Streptococcus dysgalactiae, Staphylococcus aureus and E. coli, in lactating dairy cows.
For further product information, visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
The committee heard five charges against Dr Davies at a resumed hearing of an inquiry which was originally adjourned in January and then July 2018. The decision was made, at both the 2018 hearings, to postpone the final decision on the sanction.
The first two charges against Dr Davies related to convictions for drink driving in March 2014 and October 2015 for which she received driving bans of 17 and 45 months.
The third charge related to her breaching a number of undertakings she had entered into as part of the College’s Health Protocol, including her consuming alcohol on four occasions between May 2015 and January 2016 and missing a pre-arranged appointment with a consultant psychiatrist appointed.
The fourth and fifth charges related to being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016 which was also in breach of her undertakings under the Health Protocol.
At Dr Davies' first Disciplinary Committee hearing in January 2018, she admitted all five charges against her and also accepted that her conduct was disgraceful conduct in a professional respect.
The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At the conclusion of its hearing on 23 January 2018 the Committee decided to postpone its decision regarding sanction for six months on the basis of Dr Davies’ entering into undertakings, including not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement and to undergo blood and hair tests for alcohol consumption every two months.
At the resumed hearing on 30 July 2018, Dr Davies’ Counsel submitted on her behalf that she wished to return to practise and the Committee reviewed evidence that she provided to demonstrate she had complied with her undertakings.
However, the Committee retained concerns about Dr Davies' return to practise and therefore required her to identify a veterinary surgeon who would agree to act as her mentor, noting that the mentor would have to be acceptable to the College as someone suitable to act in that capacity.
The Committee also required the continuation of the requirements for abstinence from alcohol and the programme of blood and hair testing.
A further requirement of the Committee was that Dr Davies should make a disclosure to any new employer of her appearances before the Committee in January 2018 and in July 2018 and of the decisions it made.
The final requirement of the Committee was that the respondent should not accept a ‘sole charge position’ at any time during her employment during this next period of postponement of sanction. The Committee then directed that the hearing be postponed for a further 12 months.
The Disciplinary Committee resumed its inquiry on 7th August 2019, when Dr Davies submitted documentary proof and medical records to demonstrate she had complied with all her undertakings given at the last hearing. The Committee also heard from Dr Davies’ appointed veterinary mentor who provided a statement that concluded that she no longer needed monitoring or supervision.
The Committee then considered what sanction to impose on Dr Davies.
Ian Green, chairing the Committee and speaking on its behalf, said: "The view of the Committee is that the respondent has to date overcome her addiction to alcohol and, given that her competence as a practising veterinary surgeon is not disputed, that she should therefore be permitted to return to her chosen profession. However, in the judgment of this Committee the seriousness of the offences to which the Respondent has pleaded guilty means that a sanction of “No Further Action” cannot be justified."
The Committee therefore decided that the most proportionate sanction was for Dr Davies to be reprimanded as to the conduct she admitted at previous hearings and that she be warned as to her future conduct.
Ian added: "The respondent must understand that she has been given an opportunity to prove that, for the remainder of her time in practice, she can meet the high standards expected of all registered veterinary surgeons from both other practitioners and from members of the public who entrust the care and treatment of their animals to members of this profession."
The focus groups are part of a study which will form part of Kerrie's MBA dissertation.
Kerrie says her research topic was triggered by an analysis of leadership statistics in the veterinary profession: "There is a dearth of information about the number of leadership roles occupied by women in the veterinary profession.
"We knew that in the XLVets community, our joint efforts to run leadership programmes and help aspiring owners have meant that one in five of our practice owners are women but we don't know how that compares with other veterinary sectors and business models.
"We'd like to see many, many more women in strategic positions within our community and in the wider profession. This research will look at the barriers to leadership that women might experience and will help us develop enabling and support strategies."
Kerrie says there is some interesting data coming from her own company: "When we look at the numbers, our entry level leadership programmes are almost completely female in terms of uptake and our recent aspiring owner meeting had an equal male-female split, which was great to see. So, our feeling is that we are starting to see the impact of more female graduates coming through. Whether that's happening as quickly as it should do throughout the profession is another matter and we hope the research will throw some light on this."
Female veterinary surgeons both within and outside the XLVet community, in leadership positions, aspiring to leadership, or leadership-averse and from any sphere of veterinary practice are invited to contact Kerrie to take part and contribute. She hopes to share the results of her work with the profession towards the end of the year.
Anyone wanting to take part should email Kerrie at kerrie.hedley@xlvets.co.uk.